Could a pill replace IVF shots? new study tests oral drug
NCT ID NCT05994378
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 3 trial tested whether an oral tablet called SHR7280 works as well as the standard injection (ganirelix) for preventing early ovulation in women undergoing IVF. The study involved 317 infertile women aged 20-39. If effective, the pill could offer a more convenient option, but it is not a cure for infertility—it is a tool to improve the success of IVF procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SHR7280 (oral tablet) and ganirelix acetate (injection)
What this could lead to
If successful, this could offer a more convenient oral alternative to daily injections for women undergoing IVF, potentially reducing discomfort and simplifying treatment.
What could go wrong
This is a non-inferiority trial, meaning it aims to show SHR7280 is not worse than the existing injection, not necessarily better. The results may not apply to all infertility patients, and oral medications can have different side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILE FEMALE SUBJECTS UNDERGOING CONTROLLED OVARIAN HYPERSTIMULATION TO SUPPRESS PREMATURE LH SURGE AND PREVENT EARLY OVULATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China